Literature DB >> 7512051

Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C.

N Napoli1, G Fiore, F Vella, G Fera, O Schiraldi.   

Abstract

In this study, 108 family members of 40 chronically HCV-infected patients (19 post-transfusion and 21 sporadic), and 45 families of 16 anti-HCV-negative index cases (control group) were tested for anti-HCV antibodies. Anti-HCV antibodies were found in 16 (14.8%) families of anti-HCV-positive index cases (15% males and 14.6% females; p = NS), with no difference between families of index cases with post-transfusion and those with sporadic HCV infection. Out of the 16 anti-HCV positive family members, 12 (75%) had clinical and/or serological evidence of chronic liver damage. None of the control group subjects were anti-HCV-positive (p < 0.01). The rate of anti-HCV positivity was 34.4% among spouses, 14.3% among siblings, 16.7% among cohabitants and 2.3% among children; anti-HCV antibodies were not detected among parents. We found a positive correlation between the prevalence of anti-HCV antibodies among families and the severity of the HCV-related chronic liver damage of the index cases (p < 0.00005). In addition, to confirm that HCV infection and HCV-related chronic hepatitis may be transmitted intrafamiliarly, our findings also indicate that horizontal, especially sexual contact, is a more important route of HCV infection than vertical/perinatal transmission. Finally, the risk of acquiring HCV infection among families appears to be the highest when index cases are suffering from severe HCV-related chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7512051     DOI: 10.1007/bf00211437

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

1.  Hepatitis C virus RNA in saliva.

Authors:  K Takamatsu; Y Koyanagi; K Okita; N Yamamoto
Journal:  Lancet       Date:  1990-12-15       Impact factor: 79.321

2.  Prevalence of anti-HCV antibody in blood donors in the Tokyo area.

Authors:  J Watanabe; K Minegishi; T Mitsumori; M Ishifuji; T Oguchi; M Ueda; E Tokunaga; E Tanaka; K Kiyosawa; S Furuta
Journal:  Vox Sang       Date:  1990       Impact factor: 2.144

3.  Antibodies to hepatitis C virus in Italian blood donors.

Authors:  G Sirchia; A Bellobuono; A Giovanetti; M Marconi
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

4.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis.

Authors:  M J Alter; P J Coleman; W J Alexander; E Kramer; J K Miller; E Mandel; S C Hadler; H S Margolis
Journal:  JAMA       Date:  1989-09-01       Impact factor: 56.272

5.  Intrafamilial transmission of hepatitis C virus in Japan.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; S Shimizu; S Furuta; Y Miyazaki; Y Akahane; H Suzuki
Journal:  J Med Virol       Date:  1991-02       Impact factor: 2.327

6.  Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: relationship between anti-HCV antibody and the prognosis of non-A, non-B post-transfusion hepatitis.

Authors:  E Tanaka; K Kiyosawa; T Sodeyama; Y Nakano; K Yoshizawa; T Hayata; S Shimizu; Y Nakatsuji; Y Koike; S Furuta
Journal:  J Med Virol       Date:  1991-02       Impact factor: 2.327

7.  Vertical transmission of hepatitis C virus.

Authors:  M M Thaler; C K Park; D V Landers; D W Wara; M Houghton; G Veereman-Wauters; R L Sweet; J H Han
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

8.  Intrafamilial transmission of hepatitis C.

Authors:  M Takahashi; G Yamada; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1991-08

9.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

10.  Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C.

Authors:  M W Fried; M Shindo; T L Fong; P C Fox; J H Hoofnagle; A M Di Bisceglie
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

View more
  8 in total

Review 1.  Hepatitis C in childhood.

Authors:  F Bortolotti
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

Review 2.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  Intrafamilial transmission of hepatitis C virus infection.

Authors:  Eliseo Minola; Vincenzo Baldo; Tatjana Baldovin; Renzo Trivello; Annarosa Floreani
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

4.  Hepatitis C virus seroconversion in a hemophiliac treated exclusively with solvent/detergent-treated clotting factor concentrate.

Authors:  S A Evensen; H Rollag; A Glomstein
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

Review 5.  Hepatitis C infection after blood product transfusion.

Authors:  D A Kelly
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

6.  Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions.

Authors:  Cédric Laouénan; Sabine Plancoulaine; Mostafa Kamal Mohamed; Naglaa Arafa; Iman Bakr; Mohamed Abdel-Hamid; Claire Rekacewicz; Dorothée Obach; Arnaud Fontanet; Laurent Abel
Journal:  Hum Genet       Date:  2009-07-23       Impact factor: 4.132

7.  Correlates of HCV seropositivity among familial contacts of HCV positive patients.

Authors:  Giuseppe La Torre; Luca Miele; Alice Mannocci; Giacomina Chiaradia; Filippo Berloco; Maria L Gabrieli; Giovanni Gasbarrini; Maria Giovanna Ficarra; Antonio Matera; Gualtiero Ricciardi; Antonio Grieco
Journal:  BMC Public Health       Date:  2006-09-25       Impact factor: 3.295

8.  Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt.

Authors:  Maha Z Omar; Mohamed A Metwally; Hala M El-Feky; Inas A Ahmed; Mohamed A Ismail; Amal Idris
Journal:  Hepat Med       Date:  2017-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.